Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

16 Feb 2012 07:00

RNS Number : 5060X
Halma PLC
16 February 2012
 



Halma p.l.c.

 

Interim Management Statement

 

16 February 2012

 

 

Halma, the leading safety, health and environmental technology group today makes an Interim Management Statement prior to its financial year end on 31 March 2012, covering the period from 2 October 2011 to date.

 

Based on current trading and forecasts, the Board expects profit (before amortisation of acquired intangibles and acquisition costs) for the full year to be in line with market expectations [see note 2].

 

The regional and sector trading patterns reported for the first six months of the financial year have been maintained with slower growth in the UK but higher rates of growth in the USA. Good rates of growth have continued elsewhere including Mainland Europe and emerging markets.

 

Our Industrial Safety businesses continue to deliver very strong results and are all benefitting from increasing revenue from customers in the natural resources and process industries worldwide.

 

Our Health and Analysis sector is achieving the highest rate of revenue growth of the Group, boosted by acquisitions made last year. Water and Health Optics are performing well whilst Photonics and Fluid Technology are trading in line with the first six months.

 

In Infrastructure Sensors, Fire Detection and Automatic Door Sensors are making solid progress. Security Sensors and Elevator Safety are reporting flat revenues in tough market conditions.

 

The two businesses we acquired in the first half, Kirk Key Interlock Company, LLC (Industrial Safety) and Avo Photonics, Inc (Health & Analysis) are trading well and in line with our expectations.

 

We have maintained strong returns and good cash generation. This, together with the £260m 5-year revolving credit facility put in place in October 2011, provides us with financial capacity for further acquisitions. We continue to search for opportunities in all three sectors.

 

There have been no material events or transactions impacting the Group's financial position which remains strong.

 

The results for the financial year ending 31 March 2012 are expected to be released on 14 June 2012.

 

 

For further information, please contact:

 

Halma p.l.c.

Andrew Williams, Group Chief Executive

Kevin Thompson, Group Finance Director

Tel: +44 (0)1494 721111

 

MHP

Rachel Hirst/Andrew Jaques

 

Tel: +44 (0)20 3128 8100

 

 

Notes:

 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

The Board believes current market forecasts to be in the range of £118.8m to £122.5m with a consensus of £120.6m (2010/11 profit before amortisation of acquired intangibles and acquisition costs: £104.6m).

 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMGMZVKMGZZM
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.